Cargando…
Scaling up COVID-19 rapid antigen tests: promises and challenges
WHO recommends a minimum of 80% sensitivity and 97% specificity for antigen-detection rapid diagnostic tests (Ag-RDTs), which can be used for patients with symptoms consistent with COVID-19. However, after the acute phase when viral load decreases, use of Ag-RDTs might lead to high rates of false ne...
Autores principales: | Peeling, Rosanna W, Olliaro, Piero L, Boeras, Debrah I, Fongwen, Noah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906660/ https://www.ncbi.nlm.nih.gov/pubmed/33636148 http://dx.doi.org/10.1016/S1473-3099(21)00048-7 |
Ejemplares similares
-
SARS-CoV-2 rapid antigen detection tests – Authors' reply
por: Peeling, Rosanna W, et al.
Publicado: (2021) -
Serology testing in the COVID-19 pandemic response
por: Peeling, Rosanna W, et al.
Publicado: (2020) -
Need for sustainable biobanking networks for COVID-19 and other diseases of epidemic potential
por: Peeling, Rosanna W, et al.
Publicado: (2020) -
Rolling out COVID-19 antigen rapid diagnostic tests: the time is now
por: Peeling, Rosanna W, et al.
Publicado: (2021) -
Connected diagnostics systems: The future of disease control in Africa
por: Fongwen, Noah, et al.
Publicado: (2020)